Revenue
2014
2019
2020
2021
2022
2023
2024
2025
VOLITIONRX LTD (VNRX)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.7M | $1.2M | $775,302 | $306,392 | $90,035 | $13,433 | $17,096 | — | — | — | — | $14,785 | — | $54,968 | $0 |
| Research & development | $10.1M | $14.4M | $19.6M | $15.3M | $13.0M | $14.5M | $10.4M | $10.9M | $8.0M | $7.9M | $6.1M | $4.0M | $2.5M | $2.8M | $1.5M |
| Operating expenses | $23.5M | $28.3M | $36.8M | $32.1M | $28.4M | $21.3M | $16.1M | $17.9M | $14.7M | $12.4M | $10.0M | $6.0M | $4.6M | $4.1M | $2.6M |
| Operating income | −$21.7M | −$27.0M | −$36.0M | −$31.8M | −$28.3M | −$21.2M | −$16.0M | −$17.9M | −$14.7M | −$12.4M | −$10.0M | −$6.0M | −$4.6M | −$4.1M | −$2.6M |
| EBITDAderived | −$20.8M | −$25.9M | −$34.8M | −$30.8M | −$27.4M | −$20.5M | −$15.4M | −$17.3M | −$14.2M | −$12.1M | −$9.8M | −$5.8M | −$4.4M | −$3.9M | −$2.5M |
| Net income | −$23.4M | −$27.0M | −$35.7M | −$30.6M | −$27.0M | −$20.4M | −$16.1M | −$18.0M | −$14.8M | −$11.9M | −$9.5M | −$8.2M | −$3.7M | −$4.1M | −$2.6M |
| Basic EPSper diluted share | — | — | — | — | -$0.51 | -$0.45 | -$0.41 | -$0.57 | -$0.56 | -$0.52 | -$0.54 | -$0.61 | -$0.34 | -$0.44 | -$0.45 |
| Diluted EPSper diluted share | — | -$0.31 | -$0.50 | — | -$0.51 | -$0.45 | -$0.41 | -$0.57 | -$0.56 | -$0.52 | -$0.54 | -$0.61 | -$0.34 | -$0.44 | -$0.45 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Nov 17, 2025Form 4 | Reynolds Cameron JohnPresident and CEO | BuyCommon Stock | 20.0K | $0.35 | $7.0K | 2.55M |
| Oct 14, 2025Form 4 | Reynolds Cameron JohnPresident and CEO | BuyCommon Stock | 110.0K | $0.51 | $56.1K | 2.53M |
| Oct 14, 2025Form 4 | Reynolds Cameron JohnPresident and CEO | BuyWarrant (Right to Buy) · derivative | 110.0K | $0.01 | $1.1K | 110.0K |
| Oct 14, 2025Form 4 | Innes Guy ArchibaldDirector | BuyCommon Stock | 96.2K | $0.51 | $49.0K | 1.06M |
| Oct 14, 2025Form 4 | Innes Guy ArchibaldDirector | BuyWarrant (Right to Buy) · derivative | 96.2K | $0.01 | $961.53 | 96.2K |